Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study).

Seijas-Amigo J, Salgado-Barreira Á, Roca-Martinez C, Castelo-Dominguez R, Pérez-Álvarez MT, Ponce-Piñón B, Fernández-Silva M, Rodríguez-Barreiro M, Pereira-Pía M, Iglesias-Moreno JM, Gago-García M, Montáns-García R, Fernandez-Perez A, Fraga-Gayoso D, Fernandez-Montenegro M, Riveiro-Barciela B, Rilla-Villar N, Cardeso-Paredes B, Ribeiro-Ferreiro M, Rodriguez-Penas D, Cordero A, Rodríguez-Mañero M, González-Juanatey JR, SEVERAL INVESTIGATORS

Open source

DOI: 10.1016/j.clinthera.2026.03.012
Published: 2026 Jul
Container: Clinical therapeutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.clinthera.2026.03.012,
  title = {Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study).},
  author = {Seijas-Amigo J and Salgado-Barreira Á and Roca-Martinez C and Castelo-Dominguez R and Pérez-Álvarez MT and Ponce-Piñón B and Fernández-Silva M and Rodríguez-Barreiro M and Pereira-Pía M and Iglesias-Moreno JM and Gago-García M and Montáns-García R and Fernandez-Perez A and Fraga-Gayoso D and Fernandez-Montenegro M and Riveiro-Barciela B and Rilla-Villar N and Cardeso-Paredes B and Ribeiro-Ferreiro M and Rodriguez-Penas D and Cordero A and Rodríguez-Mañero M and González-Juanatey JR and SEVERAL INVESTIGATORS},
  year = {2026},
  journal = {Clinical therapeutics},
  doi = {10.1016/j.clinthera.2026.03.012},
  url = {https://doi.org/10.1016/j.clinthera.2026.03.012}
}

RIS

TY  - JOUR
TI  - Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study).
AU  - Seijas-Amigo J
AU  - Salgado-Barreira Á
AU  - Roca-Martinez C
AU  - Castelo-Dominguez R
AU  - Pérez-Álvarez MT
AU  - Ponce-Piñón B
AU  - Fernández-Silva M
AU  - Rodríguez-Barreiro M
AU  - Pereira-Pía M
AU  - Iglesias-Moreno JM
AU  - Gago-García M
AU  - Montáns-García R
AU  - Fernandez-Perez A
AU  - Fraga-Gayoso D
AU  - Fernandez-Montenegro M
AU  - Riveiro-Barciela B
AU  - Rilla-Villar N
AU  - Cardeso-Paredes B
AU  - Ribeiro-Ferreiro M
AU  - Rodriguez-Penas D
AU  - Cordero A
AU  - Rodríguez-Mañero M
AU  - González-Juanatey JR
AU  - SEVERAL INVESTIGATORS
PY  - 2026
JO  - Clinical therapeutics
DO  - 10.1016/j.clinthera.2026.03.012
UR  - https://doi.org/10.1016/j.clinthera.2026.03.012
ER  -

APA

J, S., Á, S., C, R., R, C., MT, P., B, P., M, F., M, R., M, P., JM, I., M, G., R, M., A, F., D, F., M, F., B, R., N, R., B, C., M, R., D, R., A, C., M, R., JR, G., & INVESTIGATORS, S. (2026). Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study).. Clinical therapeutics. https://doi.org/10.1016/j.clinthera.2026.03.012

Source records

pubmed · retrieved 2026-09-26T21:51:25.091Z